Jordan Conway

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Serigne N. Lô

AUSTRALIA

View details

John Thompson

Emeritus Professor of Melanoma & Surgical Oncology

University of Sydney

AUSTRALIA

View details

Elena Shklovskaya

Macquarie University

AUSTRALIA

View details

James Wilmott

Associate Professor

The University of Sydney Library

AUSTRALIA

View details

Helen Rizos

Macquarie University

AUSTRALIA

View details

Ines Pires da Silva

Senior Lecturer

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jordan Conway

Research Interests

Explore related searches

Contact this professor

Articles (10)

Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort

Do BRAF-targeted therapies have a role in the era of immunotherapy?

Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy

Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.

Intratumoral CD16+ macrophages are associated with clinical outcomes of patients with metastatic melanoma treated with combination anti-PD-1 and anti-CTLA-4 therapy

VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

The effect of organ-specific tumor microenvironments on response patterns to immunotherapy.

Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

Collaborators (6)

Serigne N. Lô

John Thompson

Elena Shklovskaya

James Wilmott

Helen Rizos

Ines Pires da Silva

Make your next move.